Phenyl chloroformate → Phenyl (4-{4-morpholin-4-yl-6-[(phenylsulfonyl)methyl]pyrimidin-2-yl}phenyl)carbamate
反応式
[N:1]1([C:7]2[CH:12]=[C:11]([CH2:13][S:14]([C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)(=[O:16])=[O:15])[N:10]=[C:9]([C:23]3[CH:28]=[CH:27][C:26]([NH2:29])=[CH:25][CH:24]=3)[N:8]=2)[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.C(=O)(O)[O-].[Na+].Cl[C:36]([O:38][C:39]1[CH:44]=[CH:43][CH:42]=[CH:41][CH:40]=1)=[O:37]>O1CCOCC1>[N:1]1([C:7]2[CH:12]=[C:11]([CH2:13][S:14]([C:17]3[CH:18]=[CH:19][CH:20]=[CH:21][CH:22]=3)(=[O:15])=[O:16])[N:10]=[C:9]([C:23]3[CH:24]=[CH:25][C:26]([NH:29][C:36](=[O:37])[O:38][C:39]4[CH:44]=[CH:43][CH:42]=[CH:41][CH:40]=4)=[CH:27][CH:28]=3)[N:8]=2)[CH2:2][CH2:3][O:4][CH2:5][CH2:6]1参加物
5
実験手順
(4-{4-Morpholin-4-yl-6-[(phenylsulfonyl)methyl]pyrimidin-2-yl}phenyl)amine (1 g, 2.44 mmol) was dissolved in dioxane (10 mL). Sodium bicarbonate (307 mg, 3.65 mmol) was added, followed by phenyl chloroformate (0.307 mL, 2.44 mmol) and the reaction stirred at room temperature for 2 hours. The solvent was removed in vacuo, and the resultant oil partitioned between 10 mL DCM and 10 mL water. The organic phase was dried over magnesium sulphate, filtered and concentrated in vacuo. The cream solid obtained was chromatographed on silica, eluting with 0-50% ethyl acetate in DCM, to give the desired material as a white solid (790 mg).
後処理
- customThe solvent was removed in vacuo
- customthe resultant oil partitioned between 10 mL DCM and 10 mL water
- dry with materialThe organic phase was dried over magnesium sulphate
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe cream solid obtained
- customwas chromatographed on silica
- washeluting with 0-50% ethyl acetate in DCM
出典と根拠
- ORDレコード
- ord-e758912cf1144ef8abf21ca3866c1018
- 出典データセット
- uspto-grants-2010_07
- 特許番号
- US07750003B2
反応ノート
読み込み中…